Venture capital firm Sofinnova Partners has held the first closing of Sofinnova Industrial Biotech I at EUR106 million. The fund, dedicated to renewable chemistry, follows a series of nine investments in the sector since 2009. Sofinnova IB I will be invested in start-ups along the value chain from the transformation
Hatteras Venture Partners has been selected by the State of North Carolina (NC) as the manager of the Venture Capital Multiplier Fund (VCMF), which has USD60 million in capital. A portion of the VCMF has been committed to the latest Hatteras venture capital fund, Hatteras Venture Partners V (HVP V).
Boutique asset manager Unigestion has launched Uni-Global – Alternative Risk Premia, an actively managed strategy to provide investors with cost-effective and liquid sources of returns modestly correlated to equity and bond returns. It complements Unigestion’s existing line of direct alternative offers, including the Uni-Global – Cross Asset Trend Follower, Uni-Global
Venture capital firm K2 Global has raised USD183 million in committed capital for a new fund. K2 Global works with entrepreneurs in the mobile, e-commerce, fintech, AR/VR, artificial intelligence, autonomous vehicles, and machine learning realms. K2 Global has invested USD58 million in over 10 companies to-date, including Magic Leap,
Venture capital investment firm TrueBridge Capital Partners has held the closing of its first direct investment fund, TrueBridge Direct Fund, with USD125 million in commitments, exceeding its target of USD100 million. The Direct Fund, TrueBridge's fifth fund, brings the firm's total assets under management to USD1.8 billion. The firm's previously
Euronext has announced the launch of Euronext Family Business, the first European index dedicated to family businesses, designed to highlight the performance of 90 family companies listed in the four countries covered by Euronext. Components of the Euronext Family Business Index are selected from listed companies in compartments A, B
Summa Equity’s first fund, Summa Equity Fund I, has closed with commitments of SEK4.5 billion, exceeding the initial target of SEK3.3 billion after being significantly oversubscribed. The fund size was limited to SEK4.5 billion despite oversubscription. Summa Equity was founded in 2016 by five partners brought together by a shared
BioMedPartners has held the first closing of BioMedInvest III, the firm’s third equity venture capital fund, at CHF75 million. BioMedInvest III is a healthcare venture capital fund which invests in private early-to-mid- stage companies in Switzerland, Germany and neighbouring countries of the European Union. “We are delighted that the continued
Dyal Capital Partners (Dyal), a division of Neuberger Berman Group, has closed Dyal Capital Partners III (PE), its third fund, with approximately USD5.3 billion of committed capital. Dyal increased the target fund size by over USD2.0 billion during the marketing period, as investment opportunities increased and investor interest in the
CVC Credit Partners, an alternative investment manager focused on sub-investment grade debt markets in the US and Europe, has priced its CVC Cordatus Loan Fund VIII at EUR415.6 million via Goldman Sachs. The CLO received strong investor demand across 33 investors, including five new investors to CVC Credit Partners’ European
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
